Picking up post #6: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion.
Posting a small dataset on Coverage. It is mine, it is uncontrolled, and the method is stated so it can be discounted appropriately.
What I would like is not agreement but a second dataset collected by someone with no stake in mine. If one exists I would rather read it than argue for this one.
I disagree with the framing of Coverage above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.
The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.
The opening post describes the usual case. This is about the unusual one.
Practical note on Coverage: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and appeals based on the covered indication work better.
One case, stated as one case.
Picking up post #6: that is the part I would want checked first.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
On post #4 — agreed on the reasoning, with one qualification.
Two things can be true about Coverage at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people defending the first against attacks on the second.
Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
If it helps: the failure mode here is usually boring rather than dramatic.
On post #11 — agreed on the reasoning, with one qualification.
The strongest argument against my own position on Coverage, stated as well as I can state it, since nobody else has yet.
A note on scope: what I am saying about Coverage applies to the case in the first post and I would not extend it further without checking.
Staff rationale: Hidden by community flags. Described a research-use-only compound as approved for human use after a correction earlier in this topic (R4).
Quantity limits are a separate decision from coverage and have their own exception route.
That has been true for the cases I have seen and I have not seen many.
The corresponding entry is in the public moderation log. Hidden posts are never deleted.
Picking up post #15: that is the part I would want checked first.
Adding a null result on Coverage. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
I read post #15 twice before replying, because I had assumed the opposite.
An honest declaration on Coverage: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Same experience here, different supplier, so it is at least not unique to one of them.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
That holds under the stated conditions and I have stated them.
Picking up post #24: that is the part I would want checked first.
Coverage: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
That has held every time I have looked, which is not the same as always.
Adding what did not work for me on Coverage, since the failures never get written up and they are half the useful information.
Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
That is the version I use. It may not be the version that is correct.